ROCKWELL MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ROCKWELL MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-06-30 was 0.00 shares.
- ROCKWELL MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 0.00 shares.
- ROCKWELL MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 0.00 shares.
- ROCKWELL MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-06-30 was 0.00 shares.
- ROCKWELL MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares.
- ROCKWELL MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 0.00 shares.
- ROCKWELL MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
- ROCKWELL MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 30.00K shares, a 88.79% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-14 | |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2024-08-08 | 0.00 shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-14 | 0.00 shares derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 0.00 shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2023-11-14 | |
| 2022-06-30 | 0.00 shares 10-Q · filed 2023-08-14 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-15 | |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-30 | |
| 2020-12-31 | 0.00 shares 10-K · filed 2021-03-31 | |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 30.00K shares 10-K · filed 2021-03-31 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | |
| 2019-03-31 | 30.00K shares 10-Q · filed 2019-05-10 | |
| 2018-12-31 | 267.50K shares 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |